Ducommun (DCO) has wrapped up FY 2025 with fourth quarter revenue of US$215.8 million and basic EPS of US$0.50, alongside net income of US$7.4 million. The trailing twelve month figures show revenue of US$824.7 million and a net loss of US$33.9 million tied to basic EPS of US$2.27. Over recent quarters, revenue has moved from US$197.3 million in Q4 2024 to US$215.8 million in Q4 2025, with quarterly basic EPS ranging from a loss of US$4.30 in Q3 2025 to a profit of US$0.50 in Q4 2025. For investors, the mix of quarterly profitability against a trailing loss puts the focus squarely on how durable Ducommun’s margins really are.

With the headline numbers on the table, the next step is to see how these results compare with the widely followed Ducommun narratives, highlighting where the story around growth and profitability is reinforced and where it is challenged.

Trailing Losses Despite US$824.7 million Revenue

• Over the last twelve months, Ducommun generated US$824.7 million of revenue but recorded a net loss of US$33.9 million and basic EPS of US$2.27 in loss terms, so the company is still unprofitable on this trailing view.
• Analysts' consensus view highlights higher defense and commercial aerospace activity as a key driver for future revenue. However, the cited 7.5% annual revenue growth rate trails the 10.4% US market comparator, which limits how strongly this supports the more optimistic growth story.

Volatile EPS With Q3 Loss Versus FY Profit Forecasts

• Within FY 2025, basic EPS ranged from a loss of US$4.30 in Q3 2025 to a profit of US$0.84 in Q2 and US$0.50 in Q4, while trailing twelve month earnings are reported as a loss, showing that profitability has been uneven across recent quarters.
• Bulls point to forecast earnings growth of 68.56% a year and an expected move back to profitability within three years. However, this has to be weighed against the recent EPS volatility:
  • Consensus narrative ties that future earnings path to higher margin engineered products and cost savings programs, but the Q3 2025 loss of US$64.4 million highlights the execution risk if consolidations or program ramps do not go as planned.
  • The same narrative leans on facility savings of US$11 million to US$13 million a year and margin improvement from a 5.0% profit margin today to 8.6% in three years, while the latest trailing figures still show a net loss, so the profit bridge is not yet visible in the reported numbers.

Bulls argue this kind of EPS swing is exactly what makes Ducommun interesting, but the gap between the recent loss and the profit goals is what they are betting will close over the next few years. 🐂 Ducommun Bull Case

Discounted Valuation Versus DCF And Peers

• At a current share price of US$122.40, Ducommun is cited as trading below a DCF fair value of US$157.32 and on a 2.2x P/S ratio, compared with 4.4x for the wider Aerospace & Defense industry and 11.3x for peers, so the stock sits at a lower sales multiple than these benchmarks.
• Bears focus on the fact that losses reportedly increased about 33.2% per year over the past five years and that the company is still unprofitable on a trailing twelve month basis, which creates tension with any valuation argument:
  • Critics highlight that a discount to DCF fair value only helps if the forecast turnaround to US$40.0 million of current earnings and a path to US$84.8 million by around 2028 is achieved, while the latest trailing net loss of US$33.9 million shows that turnaround is still in progress.
  • Skeptics also point out that revenue growth expectations of 7.5% a year are below the 10.4% reference rate for the US market, so the lower P/S multiple can be seen as the market pricing in slower growth and the history of worsening losses rather than offering a free bargain.

Skeptical investors often see this mix of lower P/S, DCF fair value gap and a five year loss trend as a reminder to check how much downside risk they are willing to accept if the profit recovery does not play out as modeled. 🐻 Ducommun Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Ducommun on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With all this in mind, do these results leave you optimistic or cautious about Ducommun? If you want to move quickly and shape your own view, take a closer look at the balance of risks and upsides. You can start with the 2 key rewards that investors are currently watching.

See What Else Is Out There

Ducommun is still working through trailing losses, uneven quarterly EPS and a history of worsening losses, which together underline meaningful earnings and execution risk.

If that mix of volatility and uncertainty makes you want something steadier, check out 80 resilient stocks with low risk scores to quickly focus on companies with more resilient profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.